找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiation Therapy in Hematologic Malignancies; An Illustrated Pract Bouthaina Shbib Dabaja,Andrea K. Ng Book 2017 Springer International Pu

[復(fù)制鏈接]
樓主: Gullet
21#
發(fā)表于 2025-3-25 05:06:11 | 只看該作者
22#
發(fā)表于 2025-3-25 08:32:15 | 只看該作者
23#
發(fā)表于 2025-3-25 14:12:24 | 只看該作者
24#
發(fā)表于 2025-3-25 18:12:57 | 只看該作者
25#
發(fā)表于 2025-3-25 23:17:11 | 只看該作者
26#
發(fā)表于 2025-3-26 01:07:24 | 只看該作者
Radiation Therapy in the Management of Cutaneous T-Cell Lymphomas, Radiation therapy (RT) is an important palliative treatment modality in both advanced and localized cases. In this chapter, patients with advanced and early stage MF and pcALCL will be discussed. RT management in each of these cases will be addressed.
27#
發(fā)表于 2025-3-26 05:23:55 | 只看該作者
Extranodal Marginal Zone Lymphoma,tic strategies, with a special focus on the role of radiotherapy. Current recommendations in terms of optimal dose, volumes, and techniques are also presented. Few tables summarize the results of the largest series reporting on the outcome following radiotherapy, and figures illustrate imaging features as well as contouring and planning examples.
28#
發(fā)表于 2025-3-26 09:49:49 | 只看該作者
29#
發(fā)表于 2025-3-26 14:59:38 | 只看該作者
Extranodal Marginal Zone Lymphoma,ing virtually any organ, poses several challenges. The heterogeneity of the disease also explains the uncertainty and lack of consistency in radiotherapy approaches between centers and clinicians. EN-MZL often presents with localized/organ-confined disease, and RT is generally the primary curative m
30#
發(fā)表于 2025-3-26 17:36:48 | 只看該作者
Primary Mediastinal (Thymic) Large B-Cell Lymphoma,es that differ from diffuse large B-cell lymphoma (DLBCL). In the era of immunochemotherapy, a variety of chemotherapy regimens have been used for PMBL, including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP); rituximab, methotrexate, leucovorin, doxorubicin, cycloph
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 02:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
芦溪县| 东乌珠穆沁旗| 庆元县| 汽车| 阳信县| 班玛县| 海丰县| 周至县| 科尔| 博罗县| 阿尔山市| 滦平县| 泾川县| 合山市| 闵行区| 天柱县| 庄河市| 嘉荫县| 潼关县| 芜湖县| 桂平市| 井陉县| 许昌县| 察雅县| 瓦房店市| 金阳县| 微山县| 平邑县| 上高县| 时尚| 连州市| 博爱县| 巴彦淖尔市| 岢岚县| 宁津县| 通化市| 河东区| 贵德县| 东丽区| 苗栗县| 汉中市|